• Nevirapine Tablet

    Free

    Product Composition & Strengths

    We supply this antiretroviral therapeutic in the globally accepted standard therapeutic strength optimized for adult combination maintenance therapy.

    Active IngredientStandard StrengthFormulation Delivery MatrixPrimary Clinical Function
    Nevirapine Anhydrous IP / BP / USP200 mgOral Solid Uncoated Tablet (Scored for flexible pediatric/titration dividing)The NNRTI Anchor: Suppresses viral replication loads when used in combination ARV regimens.
    ExcipientsPharma GradeLactose, Microcrystalline Cellulose, Sodium Starch GlycolateThe Delivery Core: Ensures immediate physical disintegration and release kinetics.
  • Nifedipine Tablet

    Free

    Product Composition & Structural Formats

    We manufacture Nifedipine across the complete clinical dosage spectrum, utilizing distinct release matrices calibrated for immediate stabilization or sustained, once-daily therapeutic coverage.

    Active IngredientAvailable StrengthsFormulation Matrix Delivery SystemPrimary Clinical Focus
    Nifedipine IP/BP/USP10 mgImmediate-Release / Rapid-Onset Film TabletAcute Titration / Tocolysis: For severe acute hypertension or suppression of premature labor contractions.
    Nifedipine IP/BP/USP20 mgSustained-Release (SR) Retard MatrixTwice-Daily Maintenance: Intermediate control for stable chronic hypertension.
    Nifedipine IP/BP/USP30 mgOnce-Daily Extended-Release (XR / XL) MatrixFirst-Line Chronic Care: Continuous 24-hour plasma stabilization for mild-to-moderate hypertension.
    Nifedipine IP/BP/USP60 mgOnce-Daily Extended-Release (XR / XL) MatrixHigh-Potency Control: For refractory essential hypertension and severe chronic stable angina pectoris.